[Tocilizumab in rheumatoid arthritis. Interleukin 6 as a new target].
Heinzl
Susanne
S
Arzneimittelinformation, Aulberstr 8, 72764 Reutlingen. sh@medpharm-text.de
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors; D000093242:Interleukin-6 Inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; D000093242:Interleukin-6 Inhibitors; C502936:tocilizumab